FDA Inspection 873262 — Cadila Pharmaceuticals Limited
The FDA completed an inspection of Cadila Pharmaceuticals Limited on March 28, 2014 in Ankleshwar. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- March 28, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ankleshwar (India)